Future studies should also evaluate the efficacy of chalcone 1 in both in vitro and ex vivo human models of skin aging, focusing on its impact on downstream inflammatory mediators such as PGE2, IL-1β, and IL-6, to further substantiate its potential. This evidence concerns the gene IL1B and skin aging.